SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-21-000034
Filing Date
2021-07-29
Accepted
2021-07-29 16:46:18
Documents
82
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tvtx-20210630.htm   iXBRL 10-Q 1662263
2 EX-31.1 ex06302021311.htm EX-31.1 12812
3 EX-31.2 ex06302021312.htm EX-31.2 12486
4 EX-32.1 ex06302021321.htm EX-32.1 8866
5 EX-32.2 ex06302021322.htm EX-32.2 8936
11 GRAPHIC tvtx-20210630_g1.gif GRAPHIC 81065
  Complete submission text file 0001438533-21-000034.txt   7502953

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvtx-20210630.xsd EX-101.SCH 43356
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tvtx-20210630_cal.xml EX-101.CAL 85130
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvtx-20210630_def.xml EX-101.DEF 225711
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvtx-20210630_lab.xml EX-101.LAB 556890
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvtx-20210630_pre.xml EX-101.PRE 382436
12 EXTRACTED XBRL INSTANCE DOCUMENT tvtx-20210630_htm.xml XML 1258351
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 211128160
SIC: 2834 Pharmaceutical Preparations